The Orioles have made their point in the clearest way possible: Kyle Bradish is not being treated like a short-term solution, he is being treated like part of the backbone. On July 18, 2026, Baltimore agreed to a five-year, $90MM extension with the 29-year-old right-hander, a deal that runs through 2031 and stretches well beyond the simple mechanics of an arbitration buyout.
That matters. Bradish already had two years of team control left, and this contract buys out his final two years of arbitration plus three free-agent seasons. That is not a small bet, and it is not a tentative one either. It is the Orioles saying they believe the pitcher who has worked back through elbow issues is worth building around, not merely useful while he is affordable.
David Rubenstein framed it exactly that way, saying that keeping players of Kyle’s caliber in an Orioles uniform is an important part of the club’s long-term vision and adding that the organization is grateful for his commitment to Baltimore. That is the language of a team trying to turn a good arm into a permanent answer. It is also the language of a front office that understands how quickly pitching can disappear if you wait too long to act.
A big commitment after a messy road
Bradish’s path to this point has not been smooth. In 2023, he threw a career-high 168 2/3 innings and looked like a pitcher capable of handling a serious workload. In 2024, elbow issues ended in surgery. Last year, he made a half-dozen starts at the end of the season. This past offseason, he won $3.55MM in arbitration. The numbers tell the story plainly enough: this is a pitcher whose value has had to be judged through both performance and durability, and Baltimore has decided the upside is worth the risk.
The recent production still gives the Orioles plenty to like. Bradish posted a 3.61 ERA over 19 starts last season, allowing a 4.00 mark across 72 1/3 innings in one stretch and 4.28 over 107 1/3 frames in another, with an 11.0% rate attached to the underlying line. Those are not empty numbers. They are the kind of outputs that make a front office comfortable pushing past the usual caution that follows surgery and interrupted availability.
And make no mistake, this is not just a clean little housekeeping move. It is the second long-term deal for a young Baltimore righty this season after Shane Baz’s five-year extension during the first week of the regular season. That tells you something about the Orioles’ current mood: they are not waiting for the market to tell them who matters. They are deciding early, paying up, and taking their chances on control, upside and continuity.
The Orioles are choosing certainty over hesitation
Could they have played this differently? Sure. Bradish still had two years of team control remaining, and the club could have kept the flexibility longer. But teams that only ever choose flexibility usually end up with fewer answers. Baltimore has chosen the more aggressive route, and the logic is obvious: good starting pitching is too hard to find, and a healthy, effective Bradish can be far more valuable than whatever uncertainty comes next.
The more interesting part is what the deal says about the Orioles’ self-image. This is a team behaving like a contender that intends to keep its own talent, not one that wants to keep re-entering the market and pretending it can replace every good arm with a clever transaction. Bradish through 2031 is a meaningful statement because it removes ambiguity. The Orioles are not merely hoping for stability. They are paying for it.
If they get the version of Bradish who can stay on the mound and look anything like the pitcher he has been when healthy, this will look perfectly sensible. If the elbow history turns this into a cautionary tale, the bill will sting. That is the reality of long-term pitching commitments. But Baltimore has decided the upside is worth the gamble, and in a market that punishes hesitation, that is at least an understandable way to spend $90MM.
